Literature DB >> 9185597

Emergence of subtype Zaire Ebola virus in Gabon.

V Volchkov1, V Volchkova, C Eckel, H D Klenk, M Bouloy, B LeGuenno, H Feldmann.   

Abstract

Gabon has recently been struck three times by Ebola hemorrhagic fever. The first isolate originating from the 1994 outbreak has been subjected to molecular characterization of its GP and VP24 genes. Sequence analysis demonstrates that the agent, Gabon-94 virus, belongs to subtype Zaire of Ebola virus. The isolate is closely related to the Kikwit-95 isolate, and both viruses seem to have evolved from a progenitor virus different from that of the Zaire-76 isolates. The relatively close relationship of all subtype Zaire viruses isolated at different geographical locations and up to 20 years apart suggests an extreme conservation in the yet unknown natural reservoir of Ebola viruses. The level of genetic variability in the human host might be different as indicated by the comparison of isolates from a single outbreak (Mayinga-76 and Eckron-76), but needs further investigation on clinical material of patients by PCR since both isolates have different levels of passages in tissue culture.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185597     DOI: 10.1006/viro.1997.8529

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

Authors:  R N Harty; M E Brown; G Wang; J Huibregtse; F P Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.

Authors:  Masayuki Saijo; Masahiro Niikura; Tetsuro Ikegami; Ichiro Kurane; Takeshi Kurata; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2006-04

3.  Processing of the Ebola virus glycoprotein by the proprotein convertase furin.

Authors:  V E Volchkov; H Feldmann; V A Volchkova; H D Klenk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

4.  Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus.

Authors:  M B Ruiz-Argüello; F M Goñi; F B Pereira; J L Nieva
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Variation in the glycoprotein and VP35 genes of Marburg virus strains.

Authors:  A Sanchez; S G Trappier; U Ströher; S T Nichol; M D Bowen; H Feldmann
Journal:  Virology       Date:  1998-01-05       Impact factor: 3.616

Review 6.  Clinical management of filovirus-infected patients.

Authors:  Danielle V Clark; Peter B Jahrling; James V Lawler
Journal:  Viruses       Date:  2012-09-21       Impact factor: 5.048

7.  Evolutionary history of Ebola virus.

Authors:  Y H Li; S P Chen
Journal:  Epidemiol Infect       Date:  2013-09-16       Impact factor: 4.434

8.  Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus.

Authors:  Pierre Becquart; Tanel Mahlakõiv; Dieudonné Nkoghe; Eric M Leroy
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

9.  Nonclinical safety assessment of repeated administration and biodistribution of ChAd3-EBO-Z Ebola candidate vaccine.

Authors:  Camille Planty; Guillaume Chevalier; Marie-Ève Duclos; Clémentine Chalmey; Catherine Thirion-Delalande; Cécile Sobry; Ann-Muriel Steff; Eric Destexhe
Journal:  J Appl Toxicol       Date:  2020-01-21       Impact factor: 3.446

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.